Suppr超能文献

可溶性尿激酶型纤溶酶原激活物受体与中国年轻冠心病患者的风险。

Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients.

机构信息

Department of Cardiology, Shunde Hospital, Southern Medical University, Foshan, China.

Department of Cardiology, Nanfang Hospital of Southern Medical University, Guangzhou 510515, China.

出版信息

Dis Markers. 2017;2017:4719403. doi: 10.1155/2017/4719403. Epub 2017 Oct 4.

Abstract

BACKGROUND

Soluble urokinase plasminogen activator receptor (suPAR) is a novel marker of chronic inflammation and is considered to be a risk factor for coronary artery disease (CAD) in Caucasians. This study investigated the role of suPAR in young Chinese patients with CAD.

METHODS

The study involved a total of 196 consecutive young (age ≤ 55 years) patients with angiographically proven CAD and 188 age-matched non-CAD individuals as controls. Traditional risk factors were evaluated using conventional assays, and levels of suPAR were measured by sandwich enzyme-linked immunosorbent assays.

RESULTS

Levels of suPAR were significantly correlated with age ( = 0.20, = 0.04), smoking ( = 0.33, = 0.008), body mass index ( = 0.21, = 0.03), and high-sensitivity C-reactive protein (hs-CRP; = 0.31, = 0.01). Multivariate logistic regression analysis showed that male sex (odds ratio (OR) = 3.12; 95% confidence interval (CI) = 1.18-8.25, = 0.02), smoking (OR = 3.41, 95% CI = 1.55-7.50, = 0.002), triglyceride (OR = 1.89, 95% CI = 1.10-3.25, = 0.02), high-sensitivity C-reactive protein (OR = 1.24, 95% CI = 1.02-0.03, = 0.03), and suPAR (OR = 1.37, 95% CI = 1.09-1.72, = 0.007) were independently associated with CAD risk in young patients.

CONCLUSIONS

SuPAR is a novel independent risk factor for CAD in young Chinese patients. Further studies evaluating the effect of anti-inflammatory treatment on the suPAR levels and the risk of CAD are needed.

摘要

背景

可溶性尿激酶型纤溶酶原激活物受体(suPAR)是一种新型的慢性炎症标志物,被认为是高加索人群中冠心病(CAD)的危险因素。本研究旨在探讨 suPAR 在年轻的中国 CAD 患者中的作用。

方法

本研究共纳入 196 例经血管造影证实的年轻(年龄≤55 岁)CAD 患者和 188 例年龄匹配的非 CAD 个体作为对照组。采用常规检测方法评估传统危险因素,夹心酶联免疫吸附试验检测 suPAR 水平。

结果

suPAR 水平与年龄( = 0.20, = 0.04)、吸烟( = 0.33, = 0.008)、体重指数( = 0.21, = 0.03)和高敏 C 反应蛋白(hs-CRP; = 0.31, = 0.01)显著相关。多变量 logistic 回归分析显示,男性(比值比(OR)=3.12;95%置信区间(CI)=1.18-8.25, = 0.02)、吸烟(OR=3.41,95% CI=1.55-7.50, = 0.002)、甘油三酯(OR=1.89,95% CI=1.10-3.25, = 0.02)、高敏 C 反应蛋白(OR=1.24,95% CI=1.02-0.03, = 0.03)和 suPAR(OR=1.37,95% CI=1.09-1.72, = 0.007)与年轻患者 CAD 风险独立相关。

结论

suPAR 是中国年轻 CAD 患者的一种新的独立危险因素。需要进一步研究评估抗炎治疗对 suPAR 水平和 CAD 风险的影响。

相似文献

引用本文的文献

本文引用的文献

1
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验